BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32727353)

  • 1. CGGBP1-regulated cytosine methylation at CTCF-binding motifs resists stochasticity.
    Patel M; Patel D; Datta S; Singh U
    BMC Genet; 2020 Jul; 21(1):84. PubMed ID: 32727353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGGBP1 regulates CTCF occupancy at repeats.
    Patel D; Patel M; Datta S; Singh U
    Epigenetics Chromatin; 2019 Sep; 12(1):57. PubMed ID: 31547883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGGBP1 mitigates cytosine methylation at repetitive DNA sequences.
    Agarwal P; Collier P; Fritz MH; Benes V; Wiklund HJ; Westermark B; Singh U
    BMC Genomics; 2015 May; 16(1):390. PubMed ID: 25981527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic bimodal changes in CpG and non-CpG methylation genome-wide upon CGGBP1 loss-of-function.
    Patel D; Patel M; Westermark B; Singh U
    BMC Res Notes; 2018 Jul; 11(1):419. PubMed ID: 29966527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGGBP1-dependent CTCF-binding sites restrict ectopic transcription.
    Patel D; Patel M; Datta S; Singh U
    Cell Cycle; 2021 Nov; 20(22):2387-2401. PubMed ID: 34585631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the role of the CGGBP1 protein in FMR1 gene expression.
    Goracci M; Lanni S; Mancano G; Palumbo F; Chiurazzi P; Neri G; Tabolacci E
    Eur J Hum Genet; 2016 May; 24(5):697-703. PubMed ID: 26306647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
    Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
    Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF maintains differential methylation at the Igf2/H19 locus.
    Schoenherr CJ; Levorse JM; Tilghman SM
    Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene structure and expression of the 5'-(CGG)(n)-3'-binding protein (CGGBP1).
    Naumann F; Remus R; Schmitz B; Doerfler W
    Genomics; 2004 Jan; 83(1):106-18. PubMed ID: 14667814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions.
    Feldmann A; Ivanek R; Murr R; Gaidatzis D; Burger L; Schübeler D
    PLoS Genet; 2013; 9(12):e1003994. PubMed ID: 24367273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32.
    Rosa AL; Wu YQ; Kwabi-Addo B; Coveler KJ; Reid Sutton V; Shaffer LG
    Chromosome Res; 2005; 13(8):809-18. PubMed ID: 16331412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
    Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
    J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth signals employ CGGBP1 to suppress transcription of Alu-SINEs.
    Agarwal P; Enroth S; Teichmann M; Jernberg Wiklund H; Smit A; Westermark B; Singh U
    Cell Cycle; 2016 Jun; 15(12):1558-71. PubMed ID: 25483050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus.
    Engel N; Thorvaldsen JL; Bartolomei MS
    Hum Mol Genet; 2006 Oct; 15(19):2945-54. PubMed ID: 16928784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation profiling in human Huntington's disease brain.
    De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR
    Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis.
    De Castro Valente Esteves LI; De Karla Cervigne N; Do Carmo Javaroni A; Magrin J; Kowalski LP; Rainho CA; Rogatto SR
    Int J Mol Med; 2006 Feb; 17(2):397-404. PubMed ID: 16391843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide.
    Mukhopadhyay R; Yu W; Whitehead J; Xu J; Lezcano M; Pack S; Kanduri C; Kanduri M; Ginjala V; Vostrov A; Quitschke W; Chernukhin I; Klenova E; Lobanenkov V; Ohlsson R
    Genome Res; 2004 Aug; 14(8):1594-602. PubMed ID: 15256511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region.
    Tost J; Jammes H; Dupont JM; Buffat C; Robert B; Mignot TM; Mondon F; Carbonne B; Siméoni U; Grangé G; Kerjean A; Ferré F; Gut IG; Vaiman D
    Nucleic Acids Res; 2006; 34(19):5438-48. PubMed ID: 17012269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding.
    Mujahed H; Miliara S; Neddermeyer A; Bengtzén S; Nilsson C; Deneberg S; Cordeddu L; Ekwall K; Lennartsson A; Lehmann S
    Blood; 2020 Jul; 136(3):339-352. PubMed ID: 32232485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.